NYSE •
Healthcare •
Diagnostics & Research •
Quote as of 07/02/2026
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNYSE
Market Capitalization11,112 mln
Float47.58 mln
Earnings Date08/12/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.69
Likely reliable
1-Year Forecast
215
Limited downside
Relative Strength
99
/ 100
Top performer
Debt / Equity
1.04
Elevated leverage
Pre-Tax Margin
11%
Moderate margin
Business Description
Charles River Laboratories International is a global life sciences company that supports the development of new medicines by providing research animals, laboratory testing, and drug safety evaluation services to pharmaceutical and biotechnology clients. Founded in 1947 and based in Wilmington, Massachusetts, the company operates across North America, Europe, and the Asia Pacific region. Its work spans the full early-stage drug development process, from initial discovery through preclinical testing and quality control manufacturing support.
